Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
NVIDIA
NVDA
|
+$475M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$350M |
| 4 |
Microsoft
MSFT
|
+$347M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$185M |
| 2 |
Meta Platforms (Facebook)
META
|
+$131M |
| 3 |
Arm
ARM
|
+$91.4M |
| 4 |
CRH
CRH
|
+$78.5M |
| 5 |
Unity
U
|
+$69.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.11% |
| 2 | Industrials | 9.48% |
| 3 | Financials | 7.56% |
| 4 | Consumer Discretionary | 5.65% |
| 5 | Healthcare | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
CALL
Caesars Entertainment
CZR
$6.06B
| $81.5K | ﹤0.01% |
+2,700
| New | +$76.1K |
|
2327
OptimizeRx
OPRX
$145M
| $81.4K | ﹤0.01% |
14,227
-60,534
| -81% | -$348K |
|
|
AGNT
2328
AGNT Inc
AGNT
$764M
| $80.7K | ﹤0.01% |
+14,924
| New | +$82.3K |
|
|
AFCG
2329
AFC Gamma
AFCG
$74.1M
| $80K | ﹤0.01% |
+25,801
| New | +$81.1K |
|
|
GIXXR
2330
GigCapital9 Corp Rights
GIXXR
| $79.8K | ﹤0.01% |
+280,000
| New | +$81.2K |
|
2331
Resources Connection
RGP
$149M
| $79.3K | ﹤0.01% |
+18,649
| New | +$78.3K |
|
2332
Nu Skin
NUS
$231M
| $78.9K | ﹤0.01% |
14,945
-27,129
| -64% | -$173K |
|
2333
Outdoor Holding Co
POWW
$260M
| $75.3K | ﹤0.01% |
33,023
+8,354
| +34% | +$17.2K |
|
2334
Prime Medicine
PRME
$615M
| $74.5K | ﹤0.01% |
+20,189
| New | +$67K |
|
|
BBCQW
2335
Bleichroeder Acquisition Corp II Warrants
BBCQW
| $71.9K | ﹤0.01% |
33,000
-16,950
| -34% | -$29.1K |
|
2336
Anavex Life Sciences
AVXL
$300M
| $71.4K | ﹤0.01% |
+27,577
| New | +$81.6K |
|
2337
InspireMD
NSPR
$42.1M
| $69.5K | ﹤0.01% |
+99,275
| New | +$105K |
|
2338
Information Services Group
III
$239M
| $69.1K | ﹤0.01% |
+16,812
| New | +$70.3K |
|
2339
Myriad Genetics
MYGN
$306M
| $68.8K | ﹤0.01% |
12,046
-88,662
| -88% | -$402K |
|
|
MEVOW
2340
M Evo Global Acquisition Corp II Warrants
MEVOW
| $67.7K | ﹤0.01% |
+175,861
| New | +$66.1K |
|
|
SKYA
2341
SkyAI Inc
SKYA
$56.2M
| $67.4K | ﹤0.01% |
60,693
-7,181
| -11% | -$11.5K |
|
2342
Pulmonx
LUNG
$97.1M
| $66.1K | ﹤0.01% |
50,841
+1,053
| +2% | +$1.45K |
|
2343
AudioEye
AEYE
$90.5M
| $65.8K | ﹤0.01% |
+11,333
| New | +$78.8K |
|
|
ATIIW
2344
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$18.6M
| $65.7K | ﹤0.01% |
30,000
-52,192
| -64% | -$92.7K |
|
2345
Clover Health Investments
CLOV
$2.2B
| $65.5K | ﹤0.01% |
12,500
-28,240
| -69% | -$95.9K |
|
2346
ProFrac Holding
ACDC
$880M
| $64.7K | ﹤0.01% |
11,134
-1,550
| -12% | -$10.4K |
|
|
BORR
2347
Borr Drilling
BORR
$1.39B
| $64.6K | ﹤0.01% |
15,653
-3,288
| -17% | -$17.7K |
|
2348
AirSculpt Technologies
AIRS
$198M
| $64.6K | ﹤0.01% |
+14,364
| New | +$58.2K |
|
2349
iQIYI
IQ
$1.01B
| $64.1K | ﹤0.01% |
+61,679
| New | +$71.7K |
|
|
IGACR
2350
Invest Green Acquisition Corp Rights
IGACR
| $64K | ﹤0.01% |
320,000
| – | – |
|
Similar funds
Steve Schonfeld's Q2 2026 Portfolio in Review
As of Q2 2026, Steve Schonfeld held 3,207 positions worth $27.9B, up 96% from $14.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Steve Schonfeld deployed $11.3B of net new capital in Q2 2026, opening 1,059 new positions and adding to 750 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $185M trimmed.
- Steve Schonfeld's largest Q2 2026 buy was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $689M increase.
- Steve Schonfeld's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $185M.
- Steve Schonfeld fully exited Marvell Technology in Q2 2026, selling an estimated $60.3M.
- Steve Schonfeld's ten largest holdings make up 29% of its $27.9B portfolio in Q2 2026.
- Steve Schonfeld opened 1,059 new positions and closed 651 in Q2 2026.
- Steve Schonfeld's portfolio value rose 96% quarter-over-quarter to $27.9B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.